Device Spine

Symphony

Payments companies reported to CMS as associated with Symphony. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$490Kassociated payments (2023-2025)

1,180clinicians with associated payments

5companies reporting

By year

2023 $210K

2024 $116K

2025 $164K

Payments reported as associated with Symphony, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurological Surgery $247K

Orthopaedic Surgery $108K

Orthopaedic Surgery of The Spine $86K

Pediatric Orthopaedic Surgery $17K

Physician Assistant $4,816

Surgical $1,702

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Symphony

These are the largest totals companies reported as associated with Symphony. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Daniel Sciubba	Baltimore, MD	Neurological Surgery	$70,417.19
Travis Hunt	Georgetown, KY	Orthopaedic Surgery	$51,200.03
Richard Allen	San Diego, CA	Orthopaedic Surgery of The Spine	$51,180.62
Daniel Refai	Atlanta, GA	Neurological Surgery	$20,706.37
Gregory Lanford	Nashville, TN	Neurological Surgery	$18,681.17
Brian Kaufman	Austin, TX	Pediatric Orthopaedic Surgery	$16,497.05
Sheng-Fu Lo	Great Neck, NY	Neurological Surgery	$16,036.55
Christopher Ames	San Francisco, CA	Neurological Surgery	$15,660.00
Christina Wright	Portland, OR	Neurological Surgery	$14,137.69
Annalise Larson	Rochester, MN	Orthopaedic Surgery	$12,285.00

Prescribed Symphony?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.